1. Home
  2. LBRDA vs SRRK Comparison

LBRDA vs SRRK Comparison

Compare LBRDA & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty Broadband Corporation

LBRDA

Liberty Broadband Corporation

HOLD

Current Price

$30.44

Market Cap

7.2B

ML Signal

HOLD

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$48.30

Market Cap

6.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LBRDA
SRRK
Founded
2014
2012
Country
United States
United States
Employees
1900
N/A
Industry
Cable & Other Pay Television Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
6.8B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
LBRDA
SRRK
Price
$30.44
$48.30
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
$56.17
AVG Volume (30 Days)
210.8K
1.5M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$109.28
$534.24
P/E Ratio
$8.39
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.18
$27.07
52 Week High
$90.43
$58.49

Technical Indicators

Market Signals
Indicator
LBRDA
SRRK
Relative Strength Index (RSI) 43.37 40.48
Support Level $29.39 $45.46
Resistance Level $34.90 $51.55
Average True Range (ATR) 1.27 2.53
MACD 0.03 -0.91
Stochastic Oscillator 25.25 14.13

Price Performance

Historical Comparison
LBRDA
SRRK

About LBRDA Liberty Broadband Corporation

Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services, including video, internet, voice, and mobile services; commercial services, including small and medium business and enterprise solutions; advertising services; and other services. The company's reportable segments are GCI Holdings and Charter. The firm derives the majority of its revenue from GCI Holdings.

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

Share on Social Networks: